Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery.
Sirogen™ is currently undergoing clinical trials to determine its safety and effectiveness in improving vascular access outcomes in patients requiring an arteriovenous fistula for hemodialysis.
Meet our Management Team
Meet our Board of Directors
Caution: The Sirolimus-eluting Collagen Implant is an investigational product that is not available for sale in any country.
Read our Expanded Access Policy.